Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director
23-May-2006
Med BioGene Inc. (MBI) announced the appointment of Erinn B. Broshko as Chief Executive Officer and a director of MBI.
Prior to joining MBI, Mr. Broshko was a corporate and securities lawyer with the Vancouver law firm of Farris, Vaughan, Wills & Murphy LLP. Mr. Broshko's legal practice was focussed primarily on biotechnology companies. Mr. Broshko holds a B.A. (hons) and M.A. from the University of Saskatchewan, an LL.B. from Dalhousie Law School and an M.B.A. from the University of British Columbia.
Other news from the department people
